Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Megestrol acetate
Matrix: | Human Plasma |
Assay Range: | 5.00 - 500 ng/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | HPLC-UV |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Appetite Stimulant |
Classification: | Drug Assays |
Megestrol acetate
Matrix: | Human Plasma |
Assay Range: | 10.0 - 500 ng/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | HPLC-UV |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Appetite Stimulant |
Classification: | Drug Assays |
Megestrol acetate
Matrix: | Human Plasma |
Assay Range: | 1 - 2,500 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Appetite Stimulant |
Classification: | Drug Assays |
Meloxicam
Matrix: | Human Plasma |
Assay Range: | 20 - 2,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | NSAID |
Classification: | Drug Assays |
Meloxicam
Matrix: | Human Plasma |
Assay Range: | 10 - 5,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | NSAID |
Classification: | Drug Assays |
Melphalan
Matrix: | Human Plasma |
Assay Range: | 0.2 - 200 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Memantine
Matrix: | Human Plasma |
Assay Range: | 0.1 - 20 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Dementia and Alzheimer's Disease |
Classification: | Drug Assays |
Memantine
Matrix: | Human Plasma |
Assay Range: | 0.2 - 100 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Dementia and Alzheimer's Disease |
Classification: | Drug Assays |
Mesalamine in presence of Olsalazine
Matrix: | Human Plasma |
Assay Range: | 0.1 - 12 ng/mL |
Sample Volume: | 0.25 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | NSAID |
Classification: | Drug Assays |
Metaxalone
Matrix: | Human Plasma |
Assay Range: | 25 - 6,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Muscle Relaxant |
Classification: | Drug Assays |
Metaxalone
Matrix: | Human Plasma |
Assay Range: | 25 - 12,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Muscle Relaxant |
Classification: | Drug Assays |
Metformin
Matrix: | Human Plasma |
Assay Range: | 2 to 2,000 ng/mL |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | K2 EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Metformin
Matrix: | Human Plasma |
Assay Range: | 50 - 6,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Metformin
Matrix: | Human Plasma |
Assay Range: | 20 - 5,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | |
Therapy Area: | |
Classification: | Drug Assays |
Metformin
Matrix: | Human Plasma |
Assay Range: | 10 - 5,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Metformin Glyburide
Matrix: | Human Plasma |
Assay Range: | 20 - 1,500 ng/mL 2 - 150 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Metformin in presence of Dapagliflozin and Empagliflozin
Matrix: | Human Plasma |
Assay Range: | 5 - 2,500 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Metformin in presence of Saxagliptin and 5-Hydroxy Saxagliptin
Matrix: | Human Plasma |
Assay Range: | 5 - 2,500 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Methadone
Matrix: | Human Plasma |
Assay Range: | 0.1 - 100 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Addiction |
Classification: | Drug Assays |
Methadone
Matrix: | Human Plasma |
Assay Range: | 1 - 1,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Addiction |
Classification: | Drug Assays |
Methadone R/S chiral
Matrix: | Human Plasma |
Assay Range: | 0.1 - 100 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Addiction |
Classification: | Drug Assays |
Methamphetamine
Matrix: | Human Plasma |
Assay Range: | 0.05 - 50 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Stimulant |
Classification: | Drug Assays |
Methotrexate
Matrix: | Monkey Serum |
Assay Range: | 1 - 1,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Immunosuppressant |
Classification: | Drug Assays |
Methotrexate7-Hydroxy Methotrexate
Matrix: | Human Plasma |
Assay Range: | 1 - 500 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Immunosuppressant |
Classification: | Drug Assays |
Methyl Diethyldithiocarbamate (Methyl-DDTC)
Matrix: | Human Plasma |
Assay Range: | 0.25 - 250 ng/mL |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antimutagen |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT